D
Anixa Biosciences, Inc. ANIX
$3.30 -$0.11-3.23% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2025 04/30/2025 01/31/2025 10/31/2024 07/31/2024
Net Income 19.07% 12.37% -10.44% 12.02% -4.40%
Total Depreciation and Amortization 0.00% 0.00% 0.00% 200.00% -75.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -27.94% 47.03% -20.53% -21.32% 1.56%
Change in Net Operating Assets -158.57% 127.83% -151.70% 260.30% -234.29%
Cash from Operations -0.53% 48.24% -213.27% 64.93% -81.52%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -135.57% -13.36% 211.76% -68.17% 389.93%
Cash from Investing -135.57% -13.36% 211.76% -68.17% 389.93%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 51,200.00% -- -- -- -90.69%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -823.53% 200.00% -112.23% 200.00% 93.67%
Cash from Financing 10,616.67% 205.88% -116.04% -28.86% -83.39%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -148.42% 493.12% -573.91% -80.00% 7,766.67%